Carbatrol and Convulsion - a phase IV clinical study of FDA data

Summary:

Convulsion is reported as a side effect among people who take Carbatrol (carbamazepine), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Keppra, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Convulsion when taking Carbatrol. It is created by eHealthMe based on reports of 1,844 people who have side effects when taking Carbatrol from the FDA, and is updated regularly.

What is Carbatrol?

Carbatrol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 1,979 Carbatrol users. Check the latest studies of Carbatrol.

What is Convulsion?

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body) is found to be associated with 1,845 drugs and 2,858 conditions by eHealthMe. Check the latest studies of Convulsion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

1,844 people reported to have side effects when taking Carbatrol.
Among them, 201 people (10.9%) have Convulsion.

Among these 201 people:

* Approximation only. Some reports may have incomplete information.

Do you take Carbatrol and have Convulsion?

- Check whether Convulsion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carbatrol:

Carbatrol (1,979 reports)

Convulsion treatments and more:

Convulsion (99,535 reports)

How severe was Convulsion and when was it recovered:

Convulsion in Carbatrol

Expand to all the drugs that have ingredients of carbamazepine:

Convulsion and drugs with ingredients of carbamazepine (3,815 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carbatrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Convulsion:

Convulsion (1,845 drugs)

Browse all the conditions that are associated with Convulsion:

Convulsion (2,858 conditions)

Related publications that referenced our studies

Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .
Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Carbatrol) and Carbatrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.